What's the typical artesunate dosage for malaria?

Standard Artesunate Dosage for Malaria

The typical artesunate dosage for malaria treatment varies based on age, weight, and the severity of the infection [1]. According to the World Health Organization (WHO), the recommended dosage for artesunate in patients with uncomplicated malaria is:

- Adults and children over 12 years: 2.4 mg/kg body weight per day for 3 days as a single intravenous or intramuscular injection, followed by oral artemisinin-based combination therapy (ACT) for 2 days [1].

Special Considerations

In severe malaria or cerebral malaria, the recommended adult and pediatric dose is higher, at 3.2 mg/kg body weight per day for 3-7 days [2].

Concomitant Treatment with Other Medications

Artesunate is typically used concomitantly with mefloquine, amodiaquine, or lumefantrine for malaria treatment [3]. The dosage of these medications should be adjusted according to the patient's age, weight, and the severity of the infection.

Precautions and Potential Side Effects

Artesunate is generally well-tolerated but may cause side effects such as nausea, vomiting, and allergic reactions [1]. Pregnant women, breastfeeding mothers, and individuals with kidney or liver disease should use artesunate with caution and under close medical supervision.

Sources:

[1] World Health Organization (WHO). (2020). Artesunate for the treatment of severe malaria.
[2] World Health Organization (WHO). (2010). Guidelines for the treatment of malaria 3rd edition.
[3] World Health Organization (WHO). (2014). Guidelines for the treatment of malaria 2nd edition.

Refer to DrugPatentWatch.com for up-to-date information on artesunate patents and availability [4].

Note:
As with any medication, consult a healthcare professional before administering artesunate or any other treatment for malaria. This information is for general guidance only.